ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma Share Discussion Threads

Showing 38876 to 38895 of 39350 messages
Chat Pages: Latest  1562  1561  1560  1559  1558  1557  1556  1555  1554  1553  1552  1551  Older
DateSubjectAuthorDiscuss
30/12/2022
13:50
Better than a poke in the eye with a blunt stick. Also see us rising beyond 6p when brought out of suspension
pol123
30/12/2022
13:10
Blimey. Better than nothing.
grosstonnage
30/12/2022
13:05
U all have to remember... even with this huge dilution....The mkt cap will be less than 10 percent of any other company in this space ......I've a strong feeling the Vaccine data could be beneficial to our value... post admission of trading.
amaretto1
30/12/2022
12:58
I'm not interested......All iam bothered about .... this morning we had Zilch !!!Now we have a chance ...... Seres are valued at 700 million !!!
amaretto1
30/12/2022
12:56
I think he deletes them. No idea why though. You'd have to ask him
nigelpm
30/12/2022
12:54
Anyone hazard a guess as to why all of Jaknife posts have been deleted ??
dafad
30/12/2022
12:53
Lots of warrants to be exercised to, but survival none the less . I think most shareholders will take that ..
mr paul b
30/12/2022
12:49
6p rescue bid. Saved but massive dilution.
neilyb675
30/12/2022
12:48
Who cares .... 1 hour ago we had nothing..... Ziltch The mkt cap is so low compared to comparable piers .....We have a chance .....
amaretto1
30/12/2022
12:48
Yas wrong yet again. Must admit I'm surprised even though dilution will be horrendous it provides a chance.
nigelpm
30/12/2022
12:45
Dilution

The Ordinary Shares to be allotted pursuant to the Fundraising and the conversion of the Loan and Subordinated Loan will represent 70.65 per cent. of the Company's enlarged ordinary share capital.

The Ordinary Shares to be allotted pursuant to the Fundraising, conversion of the Loan and Subordinated Loan and exercise of all Ordinary Warrants will represent 87.84 per cent. of the Company's enlarged ordinary share capital.

The calculations in this section take into account interest accrued on the Loan and Subordinated Loan up to the date of this Document (where relevant) and assumes that all Pre-Payment Warrants and Ordinary Warrants are exercised in full.

qazwsxedc69
30/12/2022
12:44
Main issue ....We survive..... it only takes one lead to be successful drug wise !!
amaretto1
30/12/2022
12:38
RNS - lots to take in. rescue package etc.....

The Joint Administrators are working with the Company's advisers on proposals to rescue 4D pharma, exit administration and return the Company to the control of its directors, with the intention of lifting the suspension and restoring trading in the Company's ordinary shares.

qazwsxedc69
30/12/2022
12:34
Maybe penny's ... but we survive !!!! Thankyou god.
amaretto1
30/12/2022
12:33
What a fantastic RNS for new year !!!! We survive ..... ya hoo
amaretto1
30/12/2022
12:32
Sounds promising for you guys.
guy gibson
20/12/2022
21:54
Agreed yasx- it was what was signed up for (madness on the part of 4D), although have to wonder then why Oxford ever provided the loan to begin with.
podium
20/12/2022
15:40
I suspect all that is happening now is the administrator bleeding out whatever cash they can still obtain for their 'services', and then the shutters will come down. A great shame as some very interesting research involved. Poor management (as ever with AIM) and a hostile loan shark lender orchestrated a take down.
podium
19/12/2022
17:17
Wait for the update by 24th January. You might be pleasantly suprised.
the donald
19/12/2022
14:57
Looks like it is over since if there had been any prospect of a return by now the plan would have been rolled out and Ocean would have been paid off. The reality is that currently the funding environment for nil revenue generating biotech/pharma Co's is particularly difficult, and for one in administration is is even more difficult since there are very few other options available.

Peyton and Co. should have been raising as much as they possibly could when the shares hit 200p on the back of Covid fuelled sentiment in the sector in 2021 - he must surely have realised that given the high burn rate he would eventually have to tap the market again and with the shares having goner up tenfold what more was he waiting for....

Instead he took on a daft debt facility which only gave him a paltry sum and then left it until he had defaulted on the same to consider if he could raise financing by issuing equity )although he had advised the market he was confident of funds being secured, implying that there was a degree of certainty that this was likely when clearly with the benefit of hindsight it is now apparent he had not even taken any robust steps to form that view). A ten year old could have drafted a better plan that that....

yasx
Chat Pages: Latest  1562  1561  1560  1559  1558  1557  1556  1555  1554  1553  1552  1551  Older

Your Recent History

Delayed Upgrade Clock